بدائل البحث:
significantly teer » significantly better (توسيع البحث), significantly weaker (توسيع البحث), significantly lower (توسيع البحث)
point decrease » point increase (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
significantly teer » significantly better (توسيع البحث), significantly weaker (توسيع البحث), significantly lower (توسيع البحث)
point decrease » point increase (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
-
1
-
2
-
3
-
4
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
منشور في 2024"…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns = not significant.…"
-
5
-
6
-
7
-
8
-
9
MiR-129-5p levels were decreased in mouse depression models.
منشور في 2025"…The Y-axis represents the fold change, while the X-axis indicates the significance of differential expression. The gray points represent miRNAs with no significant change (p < 0.05, false discovery rate (FDR) q < 0.05), while red and blue points indicate upregulated and downregulated miRNAs (p < 0.05, FDR q < 0.05), respectively. …"
-
10
-
11
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
منشور في 2025"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
-
12
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
13
-
14
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
15
-
16
-
17
-
18
Summary of post-treatment disease course measures from off-label medications clinical trials.
منشور في 2025الموضوعات: -
19
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
20
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
منشور في 2025الموضوعات: